Local administration of zoledronic acid prevents traumatic osteonecrosis of the femoral head in rat model

• Published in: Journal of orthopaedic translation 2021-03, Vol.27, p.132-138
• Main Authors: Zhao, Jun, Yue, Tian, Lu, Shibi, Meng, Haoye, Lin, Qiuxia, Ma, Haiyang, Liu, Guangbo, Li, Huo, Lu, Qiang, Wang, Aiyuan, Xu, Wenjing, Feng, Jing, Wan, Yiqun, Liao, Sida, Zhou, Xuefeng, Peng, Jiang
• Format: Article
• Language: English
• Subjects: Early stage; Local administration; Original; Osteonecrosis of the femoral head; Prevent; zoledronic acid
• ISSN: 2214-031X; 2214-0328
• DOI: 10.1016/j.jot.2020.08.005

Osteonecrosis of the femoral head (ONFH) is a refractory disease due to its unclear pathomechanism. Neither conservative treatment nor surgical treatment during the early stage of ONFH achieves satisfactory results. Therefore, this study aims to explore the available evidence on the effect of zoledronic acid on early-stage ONFH. For groups were established:the Normal group, model group, Normal saline group(NS group) and zoledronic acid-treated group. The blood supply to the femoral head of animals in the model group and zoledronic acid-treated group was interrupted via a surgical procedure, and zoledronic acid was then locally administered to the femoral head. Four weeks after surgery, all the hips were harvested and evaluated by micro-CT and histopathology(H&E staining, TRAP staining, Toluidine blue staining and masson staining). The values of BMD, BS/BV and Tb.Th in the Normal group and zoledronic acid-treated group were significantly higher than those in the model group and NS group (p ​